Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-10 Purchase |
2025-02-12 5:21 pm |
ProMIS Neurosciences Inc. | PMN | Cashman Neil Chief Scientific Officer |
15,000 | $0.973 | $14,595 | 129,921 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-11-18 Option Award |
2024-11-20 7:02 pm |
N/A 2034-11-18 |
ProMIS Neurosciences Inc. | PMN | Cashman Neil Chief Scientific Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-10-26 Option Award |
2023-10-30 7:42 pm |
N/A 2033-10-26 |
ProMIS Neurosciences Inc. | PMN | Cashman Neil Chief Scientific Officer |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-08-23 Option Award |
2023-08-25 4:15 pm |
2024-02-21 2029-02-21 |
ProMIS Neurosciences Inc. | PMN | Cashman Neil Chief Scientific Officer |
10,643 | $0 | 125,564 (Direct) |
View |
Ownership |
2022-07-07 7:24 pm |
N/A N/A |
ProMIS Neurosciences Inc. | PMN | Cashman Neil Chief Scientific Officer |
0 | $0 | 281,893 (Direct) |
View |